Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking strategy to diabetes management. These innovative therapies work by mimicking the inherent actions of GLP-1, a hormone released by the gut in https://gatherbookmarks.com/story21689661/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes